Synergy of Immune Checkpoint Blockade with a Novel Synthetic Consensus DNA Vaccine Targeting TERT-Reference-Cited by-同舟云学术

Synergy of Immune Checkpoint Blockade with a Novel Synthetic Consensus DNA Vaccine Targeting TERT

Published:2018-02 Issue:2 Volume:26 Page:435-445
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Duperret Elizabeth K.,Wise Megan C.,Trautz Aspen,Villarreal Daniel O.,Ferraro Bernadette,Walters Jewell,Yan Jian,Khan Amir,Masteller Emma,Humeau Laurent,Weiner David B.

Funder

NIH/NCI NRSA

Penn/Wistar Institute NIH SPORE

Wistar National Cancer Institute Cancer Center

W.W. Smith Family Trust

Basser Foundation

Inovio Pharmaceuticals

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference47 articles.

1. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat. Rev. Cancer,2012

2. PD-1 signaling in primary T cells;Riley;Immunol. Rev.,2009

3. CTLA-4 regulates tolerance induction and T cell differentiation in vivo;Walunas;J. Immunol.,1998

4. Tim-3: an emerging target in the cancer immunotherapy landscape;Anderson;Cancer Immunol. Res.,2014

5. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors;Duraiswamy;Cancer Res.,2013

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics;International Journal of Nanomedicine;2024-04

2. Advancements in Cancer Immunotherapy: Exploring Treatment Options;2024

3. Sustained release hydrogel for durable locoregional chemoimmunotherapy for BRAF-mutated melanoma;Journal of Controlled Release;2023-05

4. Enhancedanti-tumor efficacy through a combination of intramuscularly expressed DNA vaccine and plasmid-encoded PD-1 antibody;Frontiers in Immunology;2023-04-17

5. Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer;Biomedicines;2023-02-24